What percentage of donor DNA is removed in the MatrACELL decellularized dermis process for ArthroFLEX dermal allografts?

In the MatrACELL decellularized dermis process used for ArthroFLEX dermal allografts, 97% of donor DNA is successfully removed. This high level of DNA removal is crucial because it minimizes the risk of immune response and rejection when the allograft is implanted in a recipient. By effectively eliminating nearly all donor cellular material, the process enhances the biocompatibility and safety of the grafts, promoting optimal healing and integration into the host tissue. This makes the decellularization process a vital step in preparing the allograft for surgical use. The remaining percentage is negligible and does not pose a significant risk to the patient, making 97% the standard target for successful decellularization in this context.